Drug Search Results
Using advanced filters...
Advanced Search [+]

Gantacurium chloride

Alternative Names: gantacurium chloride
Latest Update: 2006-07-21
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: M2 Antagonist

Novel Mechanism: No

Modality: Large Molecule

Route of Administration: Injection

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Avera
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Anesthesia Related

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2004-004728-11

P2

Completed

Anesthesia Related

2005-12-13

MR/EUM202

P2

Completed

Anesthesia Related

None

Recent News Events

Date

Type

Title